CVA Family Office’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $404K | Buy |
|
|||||
|
2025
Q2 | $404K | Sell |
|
|||||
|
2025
Q1 | $578K | Buy |
|
|||||
|
2024
Q4 | $532K | Buy |
|
|||||
|
2024
Q3 | $451K | Buy |
|
|||||
|
2024
Q2 | $332K | Buy |
|
|||||
|
2024
Q1 | $367K | Buy |
|
|||||
|
2023
Q4 | $156K | Sell |
|
|||||
|
2023
Q3 | $206K | Sell |
|
|||||
|
2023
Q2 | $256K | Buy |
|
|||||
|
2023
Q1 | $274K | Sell |
|
|||||
|
2022
Q4 | $318K | Sell |
|
|||||
|
2022
Q3 | $336K | Sell |
|
|||||
|
2022
Q2 | $397K | Buy |
|
|||||
|
2022
Q1 | $358K | Buy |
|
|||||
|
2021
Q4 | $258K | Buy |
|
|||||
|
2021
Q3 | $109K | Sell |
|
|||||
|
2021
Q2 | $273K | Buy |
|
|||||
|
2021
Q1 | $199K | Buy |
|
|||||
|
2020
Q4 | $182K | Buy |
|
|||||
|
2020
Q3 | $109K | Buy |
|
|||||
|
2020
Q2 | $64K | Buy |
|
|||||
|
2020
Q1 | $28K | Buy |
|